(8-027) Evaluation of Four-Factor Prothrombin Complex Concentrate (4F-PCC) Dosing Strategies for the Reversal of Bleeding Associated with Apixaban and Rivaroxaban
Tuesday, December 5, 2023
2:00 PM – 3:30 PM
Location: Hall E, Lower Level
Co-Author(s): Heidi Clarke, Erika Dittmar, Thomas Wolfel
